| Modification of existing RPMI+B27-ins small molecule-based differentiation methodology for pluripotent cells cultured under chemically defined conditions. a) Schematic of modified differentiation protocol. b) Yield of live cells after 96 h culture in either mTeSR1 or E8. mTeSR1 cells were seeded at 1.25 x 10 5 cells per cm 2 and E8 cells at 1.25 x 10 4 cells per cm 2 , n = 3. c) Optimization of number of day after passage for highest efficiency cardiac differentiation measured by percentage TNNT2 positive cells assessed by flow cytometry, n = 3. d) Optimization of seeding density for subsequent differentiation efficacy, n = 3. e) Effect of clump (EDTA) or single cell (TrypLE) passaging method on subsequent differentiation efficiency. f) Immunofluorescence images of cells produced by E8/EDTA/RPMI+B27-ins methodology. Scale bar, 25 µM. g) Optimization of cardiac troponin T (TNNT2) flow cytometry staining, to test the specificity of our staining protocol, we stained fibroblasts (45 min primary) with the TNNT2 antibody 13-11 and demonstrated a very minor increase in staining (blue) over the isotype control (red). We also assessed additional monoclonal antibodies for cardiac troponin T (1-C11) and cardiac troponin I (7E147), each from a different manufacturer, and found similar levels of positive cell detection (~85-88%). As part of our optimization, we also assessed overnight primary antibody staining with the TNNT2 13-11 antibody and found that this method gave us significant non-specific staining in fibroblasts and raised the percentage of TNNT2+ cells to >99%. Therefore we adhered to 45 min staining as above. Optimization of recombinant human albumin supplier, n = 3. c) Optimization of rHA dose, qualitatively 500 µg/mL rHA produced the most suitable contracting monolayers whereas 750 µg/mL and above were more likely to result in the formation of three-dimensional structures, n = 7. d) Assessment of elimination of recombinant human albumin on cardiomyocyte yield when varying does of L-ascorbic acid 2-phosphate. Replacement of rHA with polyvinyl alcohol (PVA), which prevents shear stress in a similar manner to rHA, combined with varying doses of AA 2-P did not increase differentiation yield. e) Optimization of basal media, n = 3. f) Assessment of different RPMI 1640 media variants, n = 3. g) Optimization of pluripotent cell seeding density, n = 3. h) Optimization of GSK3β inhibitor; only BIO and CHIR99021 did not cause total cell death, n = 3. i) Optimization of CHIR99021 dose, n = 4. j) Optimization of Wnt inhibitor dose, n = 3. k) Optimization of Wnt-C59 dose, n = 4. Supplementary Fig. 11a . b) Cells differentiated RPMI+B27-ins. Matched to Supplementary Fig. 11a .
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Supplementary Table 1 | Analysis of components of defined media demonstrated effective for hESC cardiac differentiation. The constituent components of four defined media formulae, which have proven successful in either monolayer or embryoid body-based cardiac differentiation, were assessed to begin elucidation of macromolecules essential for cardiac differentiation. Concentration of L-glutamine/GlutaMAX is calculated as total in media, including any that is present in the basal media. Supplementary Table 2 | Optimization of minimal medium components required for efficient cardiac differentiation. a) Each of the 21 components of the media supplement 'B27 without insulin,' were subtracted one at a time. Results were scored 0, no cardiac differentiation or cell death; +, some contraction; ++, >50% contraction; and +++, >75% contraction. b) A second medium was formulated using the 10 components demonstrated to be essential in a) and each component subtracted one at a time. Only corticosterone was dispensable. c) Subtraction of any component from the 9-component media was not viable. d) Assessment of the addition of logarithmically higher or lower concentrations (x 0.1 or x 10) or the addition of components from any of the three other media formulae detailed in Supplementary Table 1 . e) A third medium was formulated with the four increased concentrations from d) and then each component was subtracted to find which are still necessary. f) A fourth 6-component medium was formulated and then each component subtracted. g) The final 3-component medium from which CDM3 was optimized. 
